Anti-PD-1 matches interferon as adjuvant therapy for acral melanoma: a retrospective study
Therapeutic Advances in Medical Oncology
Published online on April 22, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Programmed cell death protein (PD-1) inhibitors constitute the standard adjuvant therapy for cutaneous melanoma (CM), but well-established strategies for acral melanoma (AM) remain limited.Objective:To compare the efficacy of adjuvant anti-PD-1 ...
Background:Programmed cell death protein (PD-1) inhibitors constitute the standard adjuvant therapy for cutaneous melanoma (CM), but well-established strategies for acral melanoma (AM) remain limited.Objective:To compare the efficacy of adjuvant anti-PD-1 ...